Concepedia

Author

Nigel H. Russell

University of NottinghamORCID

Also Known As

A K Burnett, Eric Deconinck, M Essaoui, Mahmoud Aljurf, N H Russell, N Russell, N. H. Russell, N. Russell, N.H Russell, N.H. RUSSELL

621

Publications

24K

Citations

78

H-Index

120

Concepts

All Affiliations

University of NottinghamNottingham City HospitalCardiff UniversityNottingham University Hospitals NHS TrustUniversity College London
NH

About

Nigel H. Russell is an author at University of Nottingham specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

45

90

6.4K

2

Health Sciences

33

44

3.7K

3

Natural Sciences

1

1

31

4

Public Health

1

1

65

5

Allergy

1

1

25

Nigel H. Russell

×

235

Publications

19.4K

Citations

74

H-Index

YearCitations

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson,

New England Journal of Medicine

2016

812

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Alan K. Burnett, Robert K. Hills, Donald Milligan,

Journal of Clinical Oncology

2010

644

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell,

Journal of Clinical Oncology

2015

557

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills,

The Lancet Oncology

2015

533

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli,

The Lancet Oncology

2019

465

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills,

Journal of Clinical Oncology

2013

407

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Alan K. Burnett, Nigel H. Russell, Robert K. Hills,

Journal of Clinical Oncology

2012

402

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Oliver Goodyear, Mike Dennis, Nadira Jilani,

Blood

2012

393

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

Stephen Robinson, Anthony H. Goldstone, Stephen Mackinnon,

Blood

2002

387

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

Graham Jackson, Faith E. Davies, Charlotte Pawlyn,

The Lancet Oncology

2018

332

Page 1